XML 59 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Consolidated Revenues Generated by Unaffiliated Customers (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 100.00% 100.00% 100.00% 100.00%
Pharma Services Company A [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 68.00% (0.00%) [1] 27.00% (0.00%) [1]
Pharma Services Company B [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage (0.00%) [1] [1] 14.00% [1]
Discontinued Operations Determa Rx [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage (0.00%) [1] 89.00% 38.00% 82.00%
[1] Less than 10%